Brian M. Scott - 15 Jan 2026 Form 4/A - Amendment Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Reporting relationship: CFO/COO
Issuer ticker: AMN
Reported as of: 15 Jan 2026
Net transaction value: -$70,224
SEC form: 4/A - Amendment
Accepted by SEC: 30 Jan 2026, 10:54:22 UTC
Original report date: 16 Jan 2026
Prior SEC filing: 15 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Brian M. Scott

Key filing fact

Brian M. Scott filed Form 4/A - Amendment for AMN HEALTHCARE SERVICES INC (AMN) on 30 Jan 2026.

Key facts

This page summarizes Brian M. Scott's Form 4/A - Amendment filing for AMN HEALTHCARE SERVICES INC (AMN).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 30 Jan 2026, 10:54.

Change

Previous filing in this sequence was filed on 15 Dec 2025.
Current net transaction value: -$70,224.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001510242 Primary reporting owner

Scott Brian M.

Relationship: CFO/COO
Address: 12400 HIGH BLUFF DRIVE, SUITE 500, SAN DIEGO
Signature: /s/ Brian M. Scott
Signature date: 29 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +8,843
Change %: +113%
Price: $0.000000
Shares after: 16,685
Date: 15 Jan 2026
Ownership: Direct
Footnotes: F1

AMN transaction

Common Stock

Tax liability

Transaction value: $70,224
Shares: -3,592
Change %: -22%
Price: $19.55
Shares after: 13,093
Date: 15 Jan 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -8,843
Change %: -33%
Price: $0.000000
Shares after: 17,956
Date: 15 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,843
Exercise price
Footnotes: F3, F4, F5

AMN transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +40,920
Change %
Price: $0.000000
Shares after: 40,920
Date: 15 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,920
Exercise price
Footnotes: F5, F6, F7, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Common stock acquired on the vesting of Restricted Stock Units.

Footnote F2

Number of shares withheld for tax purposes.

Footnote F3

The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

Footnote F4

The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

Footnote F5

Restricted Stock Units do not have an expiration date.

Footnote F6

The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

Footnote F7

The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

Footnote F8

Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 40,920 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 40,920 securities were beneficially owned by reporting person, not 81,840 as previously reported.